Presentation is loading. Please wait.

Presentation is loading. Please wait.

Late-outcomes of TB-IRIS William Worodria, MBChB, MMed, PhD Senior EDCTP Fellow Infectious Disease Institute, Kampala, Uganda Mulago Hospital & Complex,

Published byGeorgiana Stone Modified over 9 years ago

Similar presentations

Presentation on theme: "Late-outcomes of TB-IRIS William Worodria, MBChB, MMed, PhD Senior EDCTP Fellow Infectious Disease Institute, Kampala, Uganda Mulago Hospital & Complex,"— Presentation transcript:

1 Late-outcomes of TB-IRIS William Worodria, MBChB, MMed, PhD Senior EDCTP Fellow Infectious Disease Institute, Kampala, Uganda Mulago Hospital & Complex, Kampala, Uganda The Rainbow of IRIS in HIV, 26th July 2012

2 Study objective To determine if there are differences in treatment outcomes between TB-HIV co-infected patients with and without TB-IRIS: CD4 changes with treatment Mortality Loss to follow up The Rainbow of IRIS in HIV, 26th July 2012

3 Methodology Site: Mulago National TB treatment centre Design: Case-control design. Inclusion criteria: – ART naïve adult patients co-infected with TB-HIV started on HAART (CD4<250) Exclusion criteria: – No treatment supporter – Severe liver/renal abnormalities Cases: patients with TB-IRIS Controls: patients without TB-IRIS -matched by baseline CD4 count (1:2) The Rainbow of IRIS in HIV, 26th July 2012

4 Results From December 2007 - July 2010, we enrolled 254 patients with TB-HIV starting ART We identified: – 61 cases of TB-IRIS and – 122 controls (no TB-IRIS) The Rainbow of IRIS in HIV, 26th July 2012

5 The Rainbow of IRIS in HIV, 26th July 2012 Median CD4 counts of patients co-infected with TB-HIV on antiretroviral therapy

6 Treatment outcomes Mortality: 6 (10%) patients with TB-IRIS died vs 18 (15%) without TB-IRIS OR mortality = 0.60, 95% CI 0.21-1.70, (p= 0.34) Loss to Follow up: 5 (8.2%) patients with TB-IRIS vs 10 (8.2%) without were lost to follow up OR loss2fu = 1.00, 95% CI 0.33- 3.04, (p=1.00) The Rainbow of IRIS in HIV, 26th July 2012

7 Conclusion TB-IRIS in this study with a small sample size had no impact on outcomes The Rainbow of IRIS in HIV, 26th July 2012

8 Acknowledgments The Rainbow of IRIS in HIV, 26th July 2012 Prof. R Colebunders Joseph Sempa All patients M-MJAP

Download ppt "Late-outcomes of TB-IRIS William Worodria, MBChB, MMed, PhD Senior EDCTP Fellow Infectious Disease Institute, Kampala, Uganda Mulago Hospital & Complex,"

Similar presentations

Tuberculosis incidence and risk factors among adult patients receiving HAART in Senegal: a 7-year cohort study Assane DIOUF et al. IRD/UMR 145 CRCF, CHNU.

Tuberculosis incidence and risk factors among adult patients receiving HAART in Senegal: a 7-year cohort study Assane DIOUF et al. IRD/UMR 145 CRCF, CHNU.
Incidence and risks factors of paradoxical tuberculosis-associated IRIS in HIV-infected adults enrolled in the CAMELIA clinical trial ANRS 1295/CIPRA KH001.

Incidence and risks factors of paradoxical tuberculosis-associated IRIS in HIV-infected adults enrolled in the CAMELIA clinical trial ANRS 1295/CIPRA KH001.
The effect of changes in Kenya HIV guidelines on proportion of patients on ART and patient characteristics at initiation in Lumumba Health Centre, Western.

The effect of changes in Kenya HIV guidelines on proportion of patients on ART and patient characteristics at initiation in Lumumba Health Centre, Western.
Risk factors and true outcomes of children lost to follow-up from antiretroviral therapy in Lilongwe, Malawi C. Ardura Gracia, H. Tweya, C Feldacker, S.

Risk factors and true outcomes of children lost to follow-up from antiretroviral therapy in Lilongwe, Malawi C. Ardura Gracia, H. Tweya, C Feldacker, S.
High Rates of Tuberculosis in Patients Accessing HAART in Rural South Africa – Implications for HIV and TB Treatment Programs Kogieleum Naidoo on behalf.

High Rates of Tuberculosis in Patients Accessing HAART in Rural South Africa – Implications for HIV and TB Treatment Programs Kogieleum Naidoo on behalf.
Recommendations of BU/HIV expert panel influenced by results from Akonolinga All BU patients should be offered quality provider-initiated HIV testing and.

Recommendations of BU/HIV expert panel influenced by results from Akonolinga All BU patients should be offered quality provider-initiated HIV testing and.
Antiretroviral therapy eligibility at enrollment and time to treatment initiation in Ethiopia Chloe A. Teasdale 1, Chunhui Wang 1, Sileshi Lulseged 1,

Antiretroviral therapy eligibility at enrollment and time to treatment initiation in Ethiopia Chloe A. Teasdale 1, Chunhui Wang 1, Sileshi Lulseged 1,
Graeme Meintjes Department of Medicine, University of Cape Town HIV Service, GF Jooste Hospital TB-IRIS Research priorities and update from Kampala workshop.

Graeme Meintjes Department of Medicine, University of Cape Town HIV Service, GF Jooste Hospital TB-IRIS Research priorities and update from Kampala workshop.
Most deaths among children enrolled in two program settings in Cambodia occur within the first 6 months after enrolment. Early mortality rates were more.

Most deaths among children enrolled in two program settings in Cambodia occur within the first 6 months after enrolment. Early mortality rates were more.
Primary Healthcare Facilities Deliver More Effective Antiretroviral Therapy: An Evaluation in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.

Primary Healthcare Facilities Deliver More Effective Antiretroviral Therapy: An Evaluation in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.
Decentralization of HIV care and treatment services in Central Province, Kenya: Adult patient characteristics and outcomes Presenting author: William Reidy,

Decentralization of HIV care and treatment services in Central Province, Kenya: Adult patient characteristics and outcomes Presenting author: William Reidy,
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,

Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
Matthew Fox Center for Global Health & Development Department of Epidemiology Boston University July 17, 2011 The first step is admitting you have a problem.

Matthew Fox Center for Global Health & Development Department of Epidemiology Boston University July 17, 2011 The first step is admitting you have a problem.
Uptake of antiretrovirals in a cohort of women involved in high risk sexual behaviour in Kampala, Uganda J.Bukenya, M. Kwikiriza, O. Musana, J. Ssensamba,

Uptake of antiretrovirals in a cohort of women involved in high risk sexual behaviour in Kampala, Uganda J.Bukenya, M. Kwikiriza, O. Musana, J. Ssensamba,
1 Is Managed Care Superior to Traditional Fee-For-Service among HIV-Infected Beneficiaries of Medicaid? David Zingmond, MD, PhD UCLA Division of General.

1 Is Managed Care Superior to Traditional Fee-For-Service among HIV-Infected Beneficiaries of Medicaid? David Zingmond, MD, PhD UCLA Division of General.
Results of the CARINEMO ANRS 12146 randomized trial comparing the efficacy and safety of nevirapine vs efavirenz for treatment of HIV-TB co-infected patients.

Results of the CARINEMO ANRS randomized trial comparing the efficacy and safety of nevirapine vs efavirenz for treatment of HIV-TB co-infected patients.
Attrition in HIV Care Attrition in HIV Care: Key Operational Challenge in implementing HIV Care and Treatment in Tanzania G R Somi _________ Ministry of.

Attrition in HIV Care Attrition in HIV Care: Key Operational Challenge in implementing HIV Care and Treatment in Tanzania G R Somi _________ Ministry of.
COST-BENEFIT OF INTEGRATING CRYPTOCOCCAL ANTIGEN SCREENING AND PREEMPTIVE TREATMENT INTO ROUTINE HIV CARE Radha Rajasingham, David Meya, Melissa Rolfes,

COST-BENEFIT OF INTEGRATING CRYPTOCOCCAL ANTIGEN SCREENING AND PREEMPTIVE TREATMENT INTO ROUTINE HIV CARE Radha Rajasingham, David Meya, Melissa Rolfes,
The impact of a limited subsidy on access to antiretroviral therapy (ART) and patient outcomes in Singapore Barnaby Young Infectious Diseases registrar.

The impact of a limited subsidy on access to antiretroviral therapy (ART) and patient outcomes in Singapore Barnaby Young Infectious Diseases registrar.
Www.aidsdatahub.org HIV and AIDS Data Hub for Asia-Pacific Review in slides Treatment Last updated: December 2014.

HIV and AIDS Data Hub for Asia-Pacific Review in slides Treatment Last updated: December 2014.

Similar presentations

Ads by Google